Aims/Hypothesis. To assess the effects of diabetes-induced activation of protein kinase C (PKC) on voltage-dependent and voltage-independent Ca 2+ influx pathways in retinal microvascular smooth muscle cells. Methods. Cytosolic Ca 2+ was estimated in freshly isolated rat retinal arterioles from streptozotocin-induced diabetic and non-diabetic rats using fura-2 microfluorimetry. Voltage-dependent Ca 2+ influx was tested by measuring rises in [Ca 2+ ] i with KCl (100 mmol/l) and store-operated Ca 2+ influx was assessed by depleting [Ca 2+ ] i stores with Ca 2+ free medium containing 5 µmol/l cyclopiazonic acid over 10 min and subsequently measuring the rate of rise in Ca 2+ on adding 2 mmol/l or 10 mmol/l Ca 2+ solution. Results. Ca 2+ entry through voltage-dependent L-type Ca 2+ channels was unaffected by diabetes. In contrast, store-operated Ca 2+ influx was attenuated. In microvessels from non-diabetic rats 20 mmol/l D-mannitol had no effect on store-operated Ca 2+ influx. Diabetic rats injected daily with insulin had store-operated Ca 2+ influx rates similar to non-diabetic control rats. The reduced Ca 2+ entry in diabetic microvessels was reversed by 2-h exposure to 100 nmol/l staurosporine, a non-specific PKC antagonist and was mimicked in microvessels from non-diabetic rats by 10-min exposure to the PKC activator phorbol myristate acetate (100 nmol/l). The specific PKCβ antagonist LY379196 (100 nmol/l) also reversed the poor Ca 2+ influx although its action was less efficacious than staurosporine. Conclusion/interpretation. These results show that store-operated Ca 2+ influx is inhibited in retinal arterioles from rats having sustained increased blood glucose and that PKCβ seems to play a role in mediating this effect. [Diabetologia (2003) Diabetic retinopathy is the most widespread complication of diabetes mellitus and is a major cause of blindness in the working population of developed countries. While the exact pathogenic basis of this condition remains ill-defined, it is clear that hyperglycaemia is a critical factor in its aetiology [1, 2] . An early effect of hyperglycaemia is a persistent dilatation of the retinal arterioles which increases ocular blood flow and leads to downstream capillary hypertension. This is thought to contribute directly to the development and progression of the disease [3, 4, 5] . The angiopathy which then develops is characterised by structural changes such as pericyte [6] and arteriolar
Diabetic retinopathy is the most widespread complication of diabetes mellitus and is a major cause of blindness in the working population of developed countries. While the exact pathogenic basis of this condition remains ill-defined, it is clear that hyperglycaemia is a critical factor in its aetiology [1, 2] . An early effect of hyperglycaemia is a persistent dilatation of the retinal arterioles which increases ocular blood flow and leads to downstream capillary hypertension. This is thought to contribute directly to the development and progression of the disease [3, 4, 5] . The angiopathy which then develops is characterised by structural changes such as pericyte [6] and arteriolar smooth muscle [7] dropout, microaneurysms [8] and capillary acellularity [9] . The empty tubes of basement membrane that remain are non-perfused [10] and this leads to regions of retinal ischaemia which precipitates a destructive neovascularisation.
As hyperglycaemia seems to be the primary factor in the development of diabetic retinopathy, considerable effort has been directed to the glucose-mediated pathogenic mechanisms that lead to the retinal vascular deterioration. One of the major pathways that could lead to diabetic retinopathy is the aberrant activation of the diacylglycerol (DAG)-protein kinase C (PKC) pathway [11] .
In the physiological context, phosphatidylinositol 4,5-disphosphate hydrolysis at the plasma membrane catalysed by receptor-activated phospholipase C becomes an important source of new DAGs that are able to activate PKCs. Receptor stimulation also commonly activates phosholipase D which catalyses phosphatidylcholine hydrolysis. The phosphatidic acid generated is dephosphorylated by phosphatidate phosphohydrolase which produces DAGs. Some DAGs are also produced in the endoplasmic reticulum as intermediates in the biosynthesis of triglycerides (de novo synthesis pathway). DAGs are phosphorylated by DAG kinases or deacylated by DAG lipases, which terminate their action. The cellular effects of DAG mediated PKC activation range from regulation of ion channel gating and permeability, receptor function, cytoskeletal structure, proliferation, apoptosis, cell division and transcription.
Diabetes causes an increase in DAG concentrations in vascular tissues associated with diabetic complications, including the retina [12] . The molecular species of these pathophysiological DAGs are consistent with them being produced by the shunting of excess glucose through the de novo synthesis pathway [13] . These in turn activate a series of enzymes, particularly the α, β and δ isoforms of PKCs [11] . In diabetic rats, PKCβII is preferentially activated in the retina [12] and animal and clinical trials have shown that some of the retinal vascular changes associated with diabetes can be reversed by blockers of PKCβ [14] . Prolonged PKC activation in diabetes could also arise through oxidative stress or increased concentrations of free fatty acids [15, 16] .
Retinal arteriole diameters are directly regulated by changes in the intracellular Ca 2+ concentrations ([Ca 2+ ] i ) of the retinal microvascular smooth muscle cells (MVSM). Regulation of [Ca 2+ ] i in vascular smooth muscle involves multiple mechanisms including Ca 2+ influx and efflux and sarcoplasmic reticulum (SR) Ca 2+ release, and reuptake. Vasoactive factors released from the endothelium and retinal tissue act to modulate retinal arteriole widths by altering the activity of these Ca 2+ handling mechanisms [17] . Arteriolar relaxation within the diabetic retina could be explained by the enhanced production of vasodilators, such as nitric oxide [18, 19, 20] or prostaglandins [21] or through a reduced responsiveness of the retinal MVSM cells to vasoconstrictors such as endothelin-1 [22] . The possibility that defects in the Ca 2+ -homeostatic mechanisms of the retinal arterioles might also contribute has yet to be examined.
Retinal MVSM cells rely upon both voltage-dependent and store-operated Ca 2+ channels for their Ca 2+ entry [17] . Unlike the voltage-dependent channels, store-operated Ca 2+ channels are not activated by changes in membrane potential, but rather through the depletion of Ca 2+ from the SR following agonist stimulation. The purpose of this study was to examine whether diabetes affects the functioning of both classes of Ca 2+ channel in rat retinal MVSM cells. PKCs are known to modify the activity of both voltagedependent and store-operated Ca 2+ channels in other types of smooth muscle [23, 24, 25] and therefore we also investigated whether PKCs were responsible for the observed changes with diabetes. Our results suggest that diabetes attenuates Ca 2+ influx in retinal MVSM cells, but that this occurs entirely through the inhibition of store-operated Ca 2+ channels. Furthermore, PKCβ seems to play a major role in mediating this effect.
Materials and methods
Experimental animals. Male Sprague-Dawley rats (200-250 g) were fed on a standard rat/mouse diet (Harlan Teklad TRM). They were injected intraperitoneally with 60 mg/kg of streptozotocin freshly dissolved in 167 mmol/l saline/20 mmol/l citrate buffer, pH 4.6. After 2 weeks the rats were weighed and blood glucose was measured using a meter and test strips. After injection (12 to 14 weeks), the rats were weighed and glucose measured again in duplicate 3 h after food deprivation. The rats were then killed by CO 2 and those that had lost weight over the 12-to 14-week period were rejected. Rats having blood glucose concentrations of less than 10 mmol/l were taken as being non-diabetic and these rats acted as controls for the streptozotocin treatment (mean glucose 5.6±0.13 mmol/l, SEM, n=24). Those above this, were deemed to be diabetic (mean glucose 28.0±0.9 mmol/l, SD, n=30, p<0.00001). In some experiments, non-injected control rats were used. We gave six rats with established diabetes daily subcutaneous injections of insulin (5 units protamine zinc) for 7 days which reduced blood glucose to 3.5±1.1 mmol/l and normalised urine output and weight gain. The investigation conformed to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996) and the United Kingdom Animals (Scientific Procedures) Act, 1986.
Microvessel preparation. Retinae were removed, lightly triturated using a Pasteur pipette having a fire-polished tip of 0.3 mm internal diameter in low Ca 2+ (see below) and centrifuged. Fura-2 AM (in 5 µl of DMSO) and detergent (Pluronic) were added to the final precipitate giving final concentrations of 5 µmol/l and 10 µmol/l respectively in 1 ml of low Ca 2+ solution. The microvessels were used after 2 h and remained viable for a further 4 h.
The homogenate was diluted with 10 volumes low Ca 2+ medium and the mixture was again triturated. Of this mixture 1 ml was pipetted into a glass bottomed recording bath at 36°C. Microvessels were anchored down with tungsten wire slips and drug solutions came via a 7-way micro-manifold.
Ca2+ microfluorimetry. The preparation was illuminated by 340/380 nm light and fluorescence measured at 510 nm using Cairn software (Kent, UK). R max and R min were obtained using amphotericin (0.2 mg/ml) with 100 mmol/l Ca 2+ or Ca 2+ free/1 mmol/l EGTA respectively and these values together with the background reading (estimated using 5 mmol/l Mn 2+ in Ca 2+ -free solution) were used in calculating [Ca 2+ ] i [26] . Although endothelial cells were still present, they neither loaded fura-2 nor contributed to the MVSM responses [17] . The outer surface of the microvessels were visually sharp and were used to measure the diameter from video recordings. Statistical analysis. Data were analysed using GraphPad Prism V3 (GraphPad Software, San Diego). Data was asymmetrically distributed and thus non-parametric statistics were used. Comparisons were made among groups of measurements using the Mann Whitney and Kruskal-Wallis tests. Significance was set at p<0.05 and multiple comparisons were made using Dunn's post test. Data are expressed as a means ± SEM. At least four rats were used per treatment group and n values within the text correspond to the numbers of microvessels tested within a given protocol.
Results
Quiescent properties of the microvessels. In both diabetic and non-diabetic rats, the smooth muscle cells formed a single continuous layer without any gaps that would otherwise suggest cell loss. Microvessels taken from either group of rats had similar diameters (23.9±2.3 µm in 43 non-diabetic compared to 23.8±1.5 µm in 52 diabetic microvessels). Resting [Ca 2+ ] i was similar for each group (69±4 nmol/l for 63 non-diabetic microvessels and 76±5 nmol/l for 106 diabetic microvessels) and none of the microvessels showed any spontaneous [Ca 2+ ] i oscillations or mechanical responses. These observations are similar to those previously described for retinal arterioles freshly dispersed from normal rat retinae.
Voltage-dependent Ca2+ channels. Larger microvessels (>20 µm diameter) possessed voltage-dependent L-type Ca 2+ channels and these were activated by adding 100 mmol/l KCl causing a rise in cytosolic Ca 2+ (Fig. 1) and a transient contraction. Microvessels from normal, STZ-injected non-diabetic and diabetic rats produced similar [Ca 2+ ] i and contractile responses to high K + solution (Table 1) .
Store-operated Ca2+ influx in retinal MVSM cells.
Store-operated Ca 2+ influx can be routinely measured ] i rise with 2 mmol/l and 10 mmol/l Ca 2+ was unaffected by diabetes. Hence this step was omitted from the remaining protocols and experiments were confined to the measurement of Ca 2+ influx rates in microvessels pre-incubated with 5 µmol/l CPA in Ca 2+ -free solution during the first 10 s of addition of 2 mmol/l or 10 mmol/l Ca 2+ solutions. The higher non-physiological Ca 2+ solution (10 mmol/l Ca 2+ ) was used to test for more subtle effects of diabetes.
Diabetes and store-operated Ca2+ influx. Store-operated Ca 2+ influx was substantially reduced in microvessels from diabetic rats (Fig. 3A,B) . As additional controls for the STZ treatment, some experiments were repeated in diabetic rats injected with insulin to normalise their blood glucose. The attenuation in store-operated Ca 2+ influx was reversed in microvessels from these rats (Fig. 3B) . To exclude any osmotic effects of the 25 mmol/l glucose, 20 mmol/l D-mannitol (5 mmol/l glucose) was tested on microvessels from non-diabetic rats. Contrary to the effects of diabetes, D-mannitol had no significant effect on Ca 2+ influx (p=0.8 and p=0.98 for 2 and 10 mmol/l Ca 2+ ; n=8).
Role of Protein Kinase Cs. Diabetic hyperglycaemia has several metabolic effects including the persistent up-regulation of some Protein Kinase C (PKC) isoforms. To test their role in store-operated Ca 2+ influx, isolated microvessels from diabetic rats were treated for 2 h with the broad spectrum PKC antagonist, staurosporine (100 nmol/l). With 2 mmol/l Ca 2+ , the Table 2 . Staurosporine (SSP) reverses the attenuated CPA-induced store-operated Ca 2+ influx in retinal arterioles from diabetic rats. Values (nmol/l/s) are Ca 2+ influx rates (means ±SEM) for "n" microvessels. *** is a p<0.001 and ns is for a p>0.05. Non-diabetic-SPP data corresponds to that for non-diabetic vessels in Fig. 3B Diabetic − SSP (1) Diabetic + SSP (2) Non-diabetic − SPP (3) store-operated Ca 2+ influx rate was completely restored to values seen in microvessels from non-diabetic rats (Table 2 ). With 10 mmol/l Ca 2+ , the effect seemed to be even greater. Staurosporine had no effect on microvessels from non-diabetic rats with either 2 mmol/l or 10 mmol/l Ca 2+ (p=0.31 and p=0.7, respectively; paired comparisons with and without staurosporine in the same rats; n=10 & 12). To further test for a role of PKCs, retinal microvessels from normal rats were exposed to the PKC activator phorbol myristate acetate (PMA; 100 nmol/l), added 10 min prior to application of 2 mmol/l or 10 mmol/l Ca 2+ . PMA severely blunted store-operated Ca 2+ influx in these microvessels (Fig. 4A,B) . The microvessels also contracted during the pre-exposure to PMA (in 2 mmol/l extracellular Ca 2+ ), even though [Ca 2+ ] i was slightly reduced (Fig. 4C) . To discount any effects of PMA unrelated to PKC activation such as direct Ca 2+ channel blockade, normal microvessels were pre-incubated in 100 nmol/l PMA for 6 h, a time scale over which PKCs are known to 'down-regulate'. In these microvessels, the Ca 2+ influx rates were normal and the microvessels seemed not to be contracted (2 mmol/l Ca 2+ p=0.6; 10 mmol/l Ca 2+ p=0.63; paired comparisons with and without PMA; n=11 & 10).
There are at least 13 different isoforms of PKC, and in the diabetic retina PKCβII is preferentially upregulated. LY379196 preferentially inhibits the two PKCβ isoforms at low concentrations (≤100 nmol/l). At 100 nmol/l, it reversed the attenuated store-operated Ca 2+ influx in diabetic microvessels, but the effect was smaller than that seen with staurosporine (Fig. 5A,B) . This difference could arise from an involvement of other PKCs blocked by staurosporine but not by LY379196, or alternatively, an independent ments such as membrane potential were affected. Since our work used the same experimental model (STZ-induced diabetic rats) and diabetic duration (3 months) as the other studies, this difference appears to arise through properties intrinsic to retinal MVSM cells. The present observation is in contrast with a previous study on bovine retinal pericytes where endothelin produced a sustained increase in cell Ca 2+ that was sensitive to L-type Ca 2+ channel blockers [33] . This Ca 2+ increase was attenuated in high glucose. However, it is now clear that a store-operated Ca 2+ entry pathway is also blocked by L-type Ca 2+ channel blockers without any depolarisation [34] . It is possible that this store-filling pathway was being attenuated by high glucose rather than the L-type Ca 2+ channels.
In contrast to the VDCCs, we found that Ca 2+ entry through store-operated Ca 2+ channels was decreased in freshly isolated intact retinal MVSM from diabetic rats. This accords with previous observations showing that hyperglycaemia can inhibit store-operated Ca 2+ influx in other tissues relevant to diabetic complications [23, 35] . The functions of Ca 2+ entry through store-operated Ca 2+ channels include: (i) regulation of smooth muscle tone [36] ; (ii) refilling of Ca 2+ stores following agonist stimulation [37, 34] (iii) modulation of numerous Ca 2+ -dependent enzymes [38, 39, 40] and (iv) control of gene expression through calcineurin-induced dephosphorylation of the transcription factor NF-AT and calmodulin stimulation of various transcription factors [41, 42] . Given this diversity of physiological regulation, inhibition of this pathway in diabetes could severely affect the functional integrity of retinal arterioles. Of particular relevance to the early stages of diabetes, reduced store-operated Ca 2+ influx could, at least in part, explain the observed dilatation of the retinal arterioles and the resulting increases in ocular blood flow. Nonetheless, in our study no differences were observed in the outer diameters of freshly isolated retinal arterioles from non-diabetic and diabetic rats. However, we found that freshly isolated retinal arterioles are already maximally dilated and cannot be widened further using vasodilators such as acetylcholine or bradykinin [17] . The diabetes-induced inhibition of store-operated Ca 2+ channels is likely to have more severe consequences for small pre-capillary arterioles than the larger trunk arterioles emanating from the optic disc. This is because the smaller pre-capillary arterioles are more limited in their Ca 2+ regulation since they lack voltage-dependent Ca 2+ channels as an alternative pathway of Ca 2+ influx [17] . This could go some way to explaining why these microvessels seem particularly vulnerable to diabetes.
Our data on the inhibition of store-operated Ca 2+ channels in diabetic retinal arterioles is consistent with an increased activation of PKC since it was reversed with the generalised PKC blocker staurosporine and mimicked in non-diabetic microvessels by effect of LY379196 on the Ca 2+ pathway. In some microvessels from non-diabetic rats, LY379196 (100 nmol/l) did slightly reduce store-operated Ca 2+ influx rates, but the effect was not consistent (2 mmol/l Ca 2+ p=0.12, 10 mmol/l Ca 2+ p=0.09; paired comparisons with and without LY379196; n=12 and 13).
Discussion
It is increasingly acknowledged that abnormal [Ca 2+ ] i homeostasis contributes to the pathogenesis of diabetic vascular complications. Several studies have found that KCl depolarisation-induced changes in [Ca 2+ ] i and contractions are diminished in both macrovascular and microvascular smooth muscle cells from diabetic rats [27, 28, 29, 30, 31] and this is thought to occur through a reduction in the density of voltage-dependent L-type Ca 2+ channels [32] (VDCC). In our study, the action of high K + was maintained in the retinal MVSM cells from diabetic rats suggesting that neither the VDCCs themselves nor their activation require- PKC activation (PMA). These findings are consistent with a similar mechanism for the glucose-induced inhibition of store-operated Ca 2+ channels in human glomerular mesangial cells [35] and contradict recent studies showing that PKCs open store-operated Ca 2+ channels in vascular myocytes [25] and glomerular mesangial cells [43] . These differences are explained by heterogeneity of store-depletion/receptor activation pathways and by tissue specificity in PKC isoform activation by diabetes/hyperglycaemia. Thus in diabetic rats, PKCβI in glomeruli and PKCβII in retinae are preferentially activated [44, 12] while Ca 2+ -store-depletion preferentially translocates PKCα and PKCγ from the cytosol to the membrane [45] .
PMA contracted retinal arterioles without any rise in Ca 2+ in apparent contradiction with our PKC hypothesis of arteriolar dilatation in diabetes. However, PMA is a broad spectrum PKC activator [46] compared to isoform selective activation in diabetes. PKCε appears to mediate Ca 2+ -independent contractions in vascular smooth muscle [47] . Although PKCε is weakly up-regulated in the diabetic retina [12] , its strong activation PMA could explain this contradiction.
We finally sought to determine the PKC isoform involvement in diabetic arterioles. The restoration of store-operated Ca 2+ influx by LY379196 suggests that PKCβ is up-regulated and implies that PKCβ could mediate the retinal vasodilatation in diabetes. However, with short durations of diabetes (2-4 weeks) retinal arteriolar constriction has been reported [49] which is also reversed by PKCβ inhibition [50] . Thus PKCβ effects could be biphasic, the earlier phase possibly occurring via induction of Et-1 [51] , or by myofilament protein phosphorylation either directly or through inhibition of myosin-light chain phosphatases [52] .
In summary, these results show that store-operated Ca 2+ influx is inhibited in retinal arterioles from rats with established diabetes by mechanisms which include PKCβ upregulation. Decreased store-operated Ca 2+ influx might contribute to the demise of the retinal MVSM cells and hence the retinal haemodynamic changes in diabetes mellitus.
